Synovial Sarcoma, X Breakpoint 2 Interacting Protein (SSX2IP) Peptide
-
- Target See all SSX2IP products
- SSX2IP (Synovial Sarcoma, X Breakpoint 2 Interacting Protein (SSX2IP))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
- Sequence
- KVHLEGFNDE DVISRQDHEQ ETEKLELEIQ QCKEMIKTQQ QLLQQQLATA
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of SSX2 IP antibody,
Alternative Names: SSX2IP control peptide, SSX2IP antibody Blocking Peptide, Anti-SSX2IP Blocking Peptide, Synovial Sarcoma X Breakpoint 2 Interacting Protein Blocking Peptide, ADIP Blocking Peptide, FLJ10848 Blocking Peptide, KIAA0923 Blocking Peptide, MGC75026 Blocking Peptide, SSX2IP, SSXIP-2, SSXIP 2, SSXIP-2 Blocking Peptide, SSXIP 2 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- SSX2IP (Synovial Sarcoma, X Breakpoint 2 Interacting Protein (SSX2IP))
- Background
- SSX2IP belongs to an adhesion system, which plays a role in the organization of homotypic, interneuronal and heterotypic cell-cell adherens junctions (AJs). It may connect the nectin-afadin and E-cadherin-catenin system through alpha-actinin and may be involved in organization of the actin cytoskeleton at AJs through afadin and alpha-actinin.
- Molecular Weight
- 68 kDa
-